Emcure Pharmaceuticals announced that the Company has received the Establishment Inspection Report (EIR) from the USFDA for its formulations facility located at G.I.D.C., Taluka - Sanand, Ahmedabad. The USFDA has classified the inspection status of the said facility as Voluntary Action Indicated (VAI) and accordingly, the inspection stands closed.